Revenue: As of FY2025 Q3, the actual value is USD 0.EPS: As of FY2025 Q3, the actual value is USD -0.07.EBIT: As of FY2025 Q3, the actual value is USD -248.88 K.<h3>Segment Revenue</h3><ul><li>The company has not commenced any operations and will not generate any operating revenues until after the completion of an initial business combination.</li></ul><h3>Operational Metrics</h3><ul><li>Net Income: For the nine months ended September 30, 2025, net income was $117,673, compared to $902,163 for the same period in 2024.</li><li>Formation and Operating Costs: For the nine months ended September 30, 2025, formation and operating costs were $512,832, compared to $700,955 for the same period in 2024.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Used in Operating Activities: For the nine months ended September 30, 2025, net cash used in operating activities was - $365,189, compared to - $480,681 for the same period in 2024.</li><li>Net Cash Provided by Investing Activities: For the nine months ended September 30, 2025, net cash provided by investing activities was $23,276,164, compared to $9,069,945 for the same period in 2024.</li><li>Net Cash Used in Financing Activities: For the nine months ended September 30, 2025, net cash used in financing activities was - $22,912,353, compared to - $8,589,358 for the same period in 2024.</li></ul><h3>Unique Metrics</h3><ul><li>Interest Earned on Cash and Investments Held in Trust Account: For the nine months ended September 30, 2025, interest earned was $630,505, compared to $1,603,118 for the same period in 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company plans to effectuate its initial business combination using cash from the proceeds of its IPO and the sale of its shares, debt, or a combination of cash, equity, and debt.</li><li>Non-Core Business: The company has entered into a merger agreement with Docter Inc., which includes earnout shares contingent upon sales targets for fiscal years 2025 and 2026.</li><li>Priority: The company has extended the deadline for completing an initial business combination multiple times, with the current deadline set for December 28, 2025.</li></ul>

AIMFINITY INVESTMENT CORP I C/WTS (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 0